>>> US Research Calls I

Research Calls I
  • Upgrades:
    • American Express (AXP) upgraded to Overweight from Neutral at JPMorgan, tgt $400
    • Atlanticus (ATLC) upgraded to Buy from Hold at Texas Capital, tgt $144
    • BeOne Medicines (ONC) upgraded to Buy from Hold at Jefferies, tgt $380
    • Biogen (BIIB) upgraded to Buy from Hold at Truist, tgt $235
    • Capital One (COF) upgraded to Buy from Hold at HSBC, tgt $229
    • Casey's General Stores (CASY) upgraded to Buy at Northcoast, tgt $950
    • Deckers Outdoor (DECK) upgraded to Buy from Hold at Jefferies, tgt $130
    • Humana (HUM) upgraded to Overweight from Equal Weight at Wells Fargo, tgt $502
    • Keysight (KEYS) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $400
    • Nio (NIO) upgraded to Buy from Neutral at Goldman, tgt $7
    • Pembina Pipeline (PBA) upgraded to Overweight from Underweight at Wells Fargo
    • Saia (SAIA) upgraded to Buy from Neutral at BofA Securities, tgt $502
    • Shopify (SHOP) upgraded to Buy from Hold at Jefferies, tgt $160
    • Solstice Advanced Materials (SOLS) upgraded to Buy from Neutral at UBS, tgt $78
    • Verra Mobility (VRRM) upgraded to Neutral from Underweight at JPMorgan, tgt $6
  • Downgrades:
    • AstraZeneca (AZN) downgraded to Hold from Buy at HSBC
    • Best Buy (BBY) downgraded to Hold from Buy at Loop Capital, tgt $82
    • Papa John's (PZZA) downgraded to Underperform from Neutral at BofA Securities, tgt $34
    • Porch Group (PRCH) downgraded to Market Perform from Outperform at Keefe Bruyette, tgt $16.25
    • ResMed (RMD) downgraded to Neutral from Buy at Citigroup, tgt $235
    • Sezzle (SEZL) downgraded to Market Perform from Outperform at Keefe Bruyette, tgt $190
    • Sun Life Financial (SLF) downgraded to In Line from Outperform at Evercore ISI
  • Others:
    • Alkermes (ALKS) resumed with a Neutral at JPMorgan, tgt $60
    • Apyx Medical (APYX) initiated with a Buy at H.C. Wainwright, tgt $7
    • Atmos Energy (ATO) initiated with an Overweight at Wells Fargo, tgt $200
    • BioCryst (BCRX) resumed with a Neutral at JPMorgan, tgt $12
    • BrightSpring Health (BTSG) initiated with a Buy at Guggenheim, tgt $81
    • Candel Therapeutics (CADL) initiated with a Buy at Stifel, tgt $22
    • Cellectar Biosciences (CLRB) initiated with a Buy at Brookline Capital Markets, tgt $15
    • Costco (COST) initiated with a Sector Perform at RBC Capital, tgt $1,000
    • Deep Fission (FISN) initiated with a Buy at Benchmark, tgt $20
    • Denali Therapeutics (DNLI) resumed with an Overweight at JPMorgan, tgt $29
    • Equillium (EQ) initiated with an Overweight at Piper Sandler
    • Erasca (ERAS) initiated with an Early-Stage Biotech rating at Goldman
    • Fastenal (FAST) initiated with a Buy at Rothschild & Co Redburn, tgt $55
    • First Carolina Financial Services (FCBM) initiated with an Outperform at Raymond James, tgt $15
    • Honeywell Aerospace (HONA) initiated with an In Line at Evercore ISI, tgt $250
    • Kardigan (KARD) initiated with a Buy at Jefferies, tgt $40
    • Kardigan (KARD) initiated with a Buy at TD Cowen, tgt $46
    • Kardigan (KARD) initiated with an Overweight at JPMorgan, tgt $51
    • Legend Biotech (LEGN) resumed with a Neutral at JPMorgan, tgt $35
    • MDU Resources (MDU) initiated with an Overweight at Wells Fargo, tgt $25
    • MSC Industrial (MSM) initiated with a Buy at Rothschild & Co Redburn, tgt $155
    • NewcelX (NCEL) initiated with a Buy at Laidlaw, tgt $23
    • Novocure (NVCR) resumed with a Neutral at JPMorgan, tgt $17
    • Park Aerospace (PKE) initiated with a Buy at Needham, tgt $43
    • Praxis Precision Medicines (PRAX) initiated with a Buy at Goldman, tgt $447
    • SiteOne Landscape Supply (SITE) initiated with an Overweight at KeyBanc, tgt $145
    • Stoke Therapeutics (STOK) initiated with a Buy at Goldman, tgt $44
    • York Space Systems (YSS) resumed with a Buy at Jefferies, tgt $32